BG31799A3 - Метод за получаване на хидантоини - Google Patents

Метод за получаване на хидантоини

Info

Publication number
BG31799A3
BG31799A3 BG044820A BG4482079A BG31799A3 BG 31799 A3 BG31799 A3 BG 31799A3 BG 044820 A BG044820 A BG 044820A BG 4482079 A BG4482079 A BG 4482079A BG 31799 A3 BG31799 A3 BG 31799A3
Authority
BG
Bulgaria
Prior art keywords
hydantoins
obtaining
proven
formulated
points
Prior art date
Application number
BG044820A
Other languages
Bulgarian (bg)
English (en)
Inventor
William Jamieson
William Ross
Robit Simmonds
John Verge
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG31799A3 publication Critical patent/BG31799A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG044820A 1978-05-23 1979-05-22 Метод за получаване на хидантоини BG31799A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (1)

Publication Number Publication Date
BG31799A3 true BG31799A3 (bg) 1982-03-15

Family

ID=10161451

Family Applications (2)

Application Number Title Priority Date Filing Date
BG043691A BG32115A4 (bg) 1978-05-23 1979-05-22 Метод за получаване на хидантоини
BG044820A BG31799A3 (bg) 1978-05-23 1979-05-22 Метод за получаване на хидантоини

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG043691A BG32115A4 (bg) 1978-05-23 1979-05-22 Метод за получаване на хидантоини

Country Status (31)

Country Link
US (2) US4241073A (cs)
EP (1) EP0005647B1 (cs)
JP (1) JPS54160373A (cs)
KR (1) KR830000635B1 (cs)
AR (2) AR225143A1 (cs)
AT (1) AT366034B (cs)
AU (1) AU530968B2 (cs)
BE (1) BE876435A (cs)
BG (2) BG32115A4 (cs)
CA (1) CA1120481A (cs)
CH (2) CH639650A5 (cs)
CS (2) CS208654B2 (cs)
DD (1) DD143769A5 (cs)
DE (1) DE2963061D1 (cs)
DK (1) DK207579A (cs)
ES (1) ES480850A1 (cs)
FI (1) FI791614A7 (cs)
FR (1) FR2426681A1 (cs)
GB (1) GB1601310A (cs)
GR (1) GR68363B (cs)
HU (1) HU184648B (cs)
IL (1) IL57343A (cs)
LU (1) LU81300A1 (cs)
MX (1) MX5604E (cs)
NZ (1) NZ190512A (cs)
PL (2) PL119612B1 (cs)
PT (1) PT69648A (cs)
RO (2) RO76807A (cs)
SU (2) SU873878A3 (cs)
YU (1) YU120179A (cs)
ZA (1) ZA792501B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
HU204047B (en) * 1987-01-31 1991-11-28 Sandoz Ag Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
DE69123738T2 (de) * 1990-04-27 1997-07-03 Orion-Yhtymae Oy, Espoo Pharmakologisch aktive catecholderivate
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
AU2351795A (en) * 1994-04-28 1995-11-29 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
DE19622489A1 (de) * 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
NZ532909A (en) * 2001-11-30 2006-08-31 Lilly Co Eli Peroxisome proliferator activated receptor agonists
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
EP2155692B1 (en) * 2007-05-30 2015-06-17 F. Hoffmann-La Roche AG Non-nucleoside reverse transcriptase inhibitors
WO2009059243A1 (en) * 2007-11-01 2009-05-07 The Uab Research Foundation Treating and preventing viral infections
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
US3365296A (en) * 1964-05-18 1968-01-23 Gen Aniline & Film Corp Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (cs) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
GR68363B (cs) 1981-12-23
JPS54160373A (en) 1979-12-19
PT69648A (en) 1979-06-01
MX5604E (es) 1983-11-07
PL125075B1 (en) 1983-03-31
SU988190A3 (ru) 1983-01-07
PL222701A1 (cs) 1980-12-15
ES480850A1 (es) 1980-02-01
BE876435A (fr) 1979-11-21
NZ190512A (en) 1984-10-19
SU873878A3 (ru) 1981-10-15
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
DK207579A (da) 1979-11-24
US4241073A (en) 1980-12-23
LU81300A1 (fr) 1980-12-16
RO76807A (ro) 1981-04-26
IL57343A0 (en) 1979-09-30
AU530968B2 (en) 1983-08-04
AR225143A1 (es) 1982-02-26
AU4728979A (en) 1979-11-29
BG32115A4 (bg) 1982-05-14
FI791614A7 (fi) 1981-01-01
RO79703A (ro) 1982-08-17
YU120179A (en) 1983-02-28
CH639650A5 (fr) 1983-11-30
AR224186A1 (es) 1981-10-30
CS208654B2 (en) 1981-09-15
PL119612B1 (en) 1982-01-30
EP0005647B1 (en) 1982-06-09
KR830000635B1 (ko) 1983-03-23
CA1120481A (en) 1982-03-23
IL57343A (en) 1982-09-30
ATA373379A (de) 1981-07-15
AT366034B (de) 1982-03-10
ZA792501B (en) 1980-05-28
DE2963061D1 (en) 1982-07-29
EP0005647A1 (en) 1979-11-28
US4293563A (en) 1981-10-06
FR2426681B1 (cs) 1983-08-12
PL215773A1 (cs) 1980-07-14
CH643546A5 (fr) 1984-06-15
GB1601310A (en) 1981-10-28
HU184648B (en) 1984-09-28
FR2426681A1 (fr) 1979-12-21

Similar Documents

Publication Publication Date Title
BG38164A3 (bg) Метод за получаване на n- заместени-4-пипериданамини
BG31799A3 (bg) Метод за получаване на хидантоини
BG39466A3 (bg) Метод за получаване на карбоксиалкилни дипептиди
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
BG31499A3 (bg) Метод за получаване на 1-винилтриазолови производни
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG38333A3 (bg) Метод за получаване на заместени фенилкарбоксиоксими
BG28847A3 (bg) Метод за получаване на хидантоинови производни
BG35327A3 (bg) Метод за получаване на пиридоксинови производни
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG32268A3 (bg) Метод за получаване на имидазолови производни
BG31493A3 (bg) Метод за получаване на фенетаноламини
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG35039A3 (bg) Метод за получаване на заместени хетероциклични феноксиамини
BG35464A3 (en) Method preparing fluorene derivatives
BG32117A4 (bg) Метод за получаване олеандомицини
BG37994A3 (bg) Метод за получаване на тетрахидрохинолинови производни
BG36631A3 (bg) Метод за получаване на сяросъдържащи изохинолинови производни
BG36344A3 (bg) Метод за получаване на 4-хинолонови производни
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони
BG35032A3 (bg) Метод за получаване на 1, 1, 2- трифенилпропенови производни
BG34455A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина